Press Release

21
April
2021
FDA grants Oxehealth Vital Signs De Novo clearance
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision

31
March
2021
FDA grants Oxehealth Vital Signs De Novo clearance; Oxehealth launches in the US
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.

08
January
2021
Oxehealth secures world-first accreditation for its vital signs technology
18
September
2018

The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.

09
December
2020
High tech sensors enhance safety on mental health wards
08
December
2020

Innovative technology is being installed on mental health wards at Midlands Partnership NHS Foundation Trust (MPFT) as part of a programme to continuously improve patient safety